Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2003
10/22/2003EP1353908A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353624A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
10/22/2003EP1178966B1 Quinoline derivatives as inhibitors of mek enzymes
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003EP1027041B1 Novel cyanoaziridines for treating cancer
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451065A Chlorohydrin and cationic compounds having high affinity for pulp paper
10/22/2003CN1451002A Indole derivatives for treating central nervous system disease
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/22/2003CN1125064C 3-pyridyl enantiomers and their use as analgesics
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/22/2003CN1125051C Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635656 Cytotoxic alkaloids halitulin
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635649 Piperazinedione compounds
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2003084953A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003WO2003084950A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084930A1 Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003053922A3 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
10/16/2003WO2003048152A3 Inflammation modulators
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002083608A3 Methods of preparing sulfinamide and sulfoxides
10/16/2003WO2002000166A3 New compounds useful as antibacterial agents
10/16/2003US20030195363 Reacting 2,5-disubstituted-phenylalkylsulfide compound with halogenating agent to produce 2,5-disubstituted-phenylsulfenylhalide compound
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195360 For therapy of oncoses
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195355 Indole-type derivatives as inhibitors of p38 kinase
10/16/2003US20030195244 Nitrogen compounds such as (6-Methoxy-1H-indol-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone, administered for prophylaxis of cancer; angiogenesis inhibitors
10/16/2003US20030195234 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/16/2003US20030195232 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195223 Antithrombotic agents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195187 For therapy of obesity or type II diabetes
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195160 Sodium channel blockers
10/16/2003US20030195110 Remaining donor atoms of the ligand are selected from the group consisting of C, N, P, As, O, S, and Se
10/16/2003CA2694410A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003CA2480482A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003CA2479777A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_
10/15/2003EP1352906A1 Compositions for prevention or treatment of hepatopathy
10/15/2003EP1352660A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351957A1 Chemical derivatives and their use as anti-telomerase agent
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351955A1 Excitatory amino acid receptor antagonists
1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 1080